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Abstract
Background Enamel matrix derivative (EMD) is an effective
biomaterial for periodontal tissue regeneration and might
stimulate angiogenesis. Tyrosine-rich amelogenin peptide
(TRAP) is present in EMD and is thought to contribute in its
biological activity. In the present study, we investigated the
effect of chemically synthesized TRAP on proliferation, mi-
gration, angiogenic structure formation, and differentiation of
human umbilical vein endothelial cells (HUVECs) in vitro.
Material and methods The effects of TRAP isolated from
EMD and chemically synthesized TRAP on proliferation/via-
bility, migration, and angiogenic structure formation were in-
vestigated. Expression of angiopoietin-2 (ang-2), von
Willebrand factor (vWF), E-selectin, intracellular adhesion
molecules 1 (ICAM-1), vascular endothelial growth factor
(VEGF) receptors FMS-like tyrosine kinase 1 (FLT-1), and
kinase insert domain receptor (KDR) was measured on both
messenger RNA (mRNA) and protein levels.
Results The proliferation/viability of HUVECs was inhibited
by TRAP at concentration of 100 μg/ml and slightly stimulat-
ed by EMD at similar concentration. Both EMD and TRAP
stimulated endothelial cell migration in microchemotaxis
chamber. The effect of both TRAP preparations on the migra-
tion was significantly higher than that of EMD. All substances
stimulated formation of angiogenic structure in vitro. The ex-
pression of ICAM-1, E-selectin, FLT-1, KDR, and vWF was
significantly increased by both TRAP and EMD at a concen-
tration 50 μg/ml. The expression of ang-2 was not affected by
TRAP but was significantly increased by EMD.
Conclusion Our in vitro study shows that TRAP confer the
most effects of EMD on the endothelial cells.
Clinical relevance TRAP might be used as a basis for devel-
opment of new approaches for periodontal regeneration.
Keywords Enamelmatrix derivative .Wound healing .
Endothelial cells . Angiogenesis
Introduction
Application of bioactive material is considered an important
approach to improve the regeneration of periodontal tissue.
Enamel matrix derivative (EMD) is a complex of low molec-
ular weight hydrophobic enamel proteins, which is derived
from developing porcine tooth buds. The EMD-based com-
mercial product Emdogain, which contains also a propylene
glycol alginate (PGA) carrier, has been used clinically since
more than 10 years, and its capacity to promote periodontal
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regeneration has been largely documented [1, 2]. The biolog-
ical effects of EMD are probably due to the presence of bio-
active compounds, which are involved in the process of teeth
development [3, 4].
Periodontium is highly vascularized tissue and therefore
success of therapy depends on the ability to promote the for-
mation of blood microvessels, which guarantee nutrition and
oxygen supply. Several in vitro and in vivo studies show that
EMD stimulates angiogenesis [5, 6], a process of new vessels
formation playing an important role in periodontal regenera-
tion and wound healing [7]. Endothelial cells (ECs), which
underlie the inner surface of the vasculature, play a key role
in the angiogenesis. The process of new vessel formation in-
cludes sprouting of ECs from the existing vessel, proliferation,
migration, and organization in the capillary network [8].
Several in vitro studies show that EMD stimulates migration,
angiogenesis, and expression of angiogenesis-related proteins
in ECs [9–12]. Moreover, EMD is recently shown to stimulate
angiogenic differentiation of periodontal ligament-derived
stem cells [13].
EMD proteins responsible for its biological activity are
not exactly identified. EMD is composed mainly from
amelogenins accounting about 90 % of all proteins [3].
Amelogenins are the family of proteins and low molecular
weight peptides derived from single gene and formed by
alternative splicing and proteolytic degradation. Besides
amelogenin proteins, EMD contains also ameloblastin,
enamelin, tuftelin, and proteolytic enzyme [3]. The mech-
anism underlying the regenerative ability of EMD as well
as an exact bioactive EMD compound(s) is a matter of
debate. Recently, a model of EMD action in vivo was pro-
posed [3]. According to this model, EMD forms in vivo a
multilayer composed of amelogenin nanospheres, which
entraps bioactive EMD components. Upon contact with
aqueous solution, bioactive compounds are released from
EMD nanospheres.
Some previous study attempted to identify proteins re-
sponsible for the angiogenic activity of EMD. Besides
whole length amelogenin, an angiogenic activity was ob-
served for EMD-derived peptide with molecular weight of
about 5 kDa, which is presumably a tyrosine-rich
amelogenin peptide (TRAP). TRAP represents N-
terminus of 20 kDa amelogenin and is a product of its
proteolytic degradation [14]. A recent study show that
chemically synthesized TRAP stimulates angiogenic differ-
entiation of human periodontal ligament stem cells [15].
However, the effect of TRAP on endothelial cells, which
play a key role in angiogenesis, is not investigated to date.
Therefore, in the present study, we investigated the effect of
TRAP on proliferation/viability, migration, and differenti-
ation of human umbilical vein endothelial cells in vitro.
Two different TRAP preparations were used: TRAP isolat-
ed from EMD and synthetic TRAP.
Material and methods
Cells and materials
Commercially available human umbilical vein endothelial
cells (HUVECs) pooled from 10 different healthy donors
(Technoclone, Vienna, Austria) were used in the present
study. HUVECs were cultured in endothelial cell medium
(ECM, Technoclone, Austria) with 20 % fetal bovine se-
rum (FBS) supplemented with 100 U/ml penicillin,
100 μg/ml streptomycin, 0.25 μg/ml fungizone, 2 mM
L-glutamine, 5 U/ml heparin, and 30–50 μg/ml endothelial
cell growth supplement in culture flasks coated with 0.2 %
gelatine at 37 °C in a humidified atmosphere of 5 % CO2
and 95 % air. The HUVECs from the 3rd to 6th passage in
culture were used.
Two different TRAP preparations were used in the pres-
ent study. First, TRAP was separated and purified from
EMD by Institut Straumann using a modification of previ-
ously described methods [16, 17]. This preparation
consisted of TRAP peptides with either 43 or 45 amino
acid residues (e-TRAP). Second, synthetic TRAP peptide
was produced by Straumann Institute. Lyophilized sub-
stances were reconstituted in 0.1 % acetic acid to produce
a 10 mg/ml stock solution. Further dilutions of proteins
(1–100 μg/ml) were performed into FBS-free ECM. In
each experiment, ECM supplemented with the acetic acid
at concentrations of 0.0001–001 % was used as a vehicle
control. No significant effect of acetic acid on any study
parameter was observed.
Cell proliferation/viability
Cell proliferation/viability was measured using 3,4,5-di-
methylthiazol-2-yl-2,5-diphenyl tetrazolium bromide
(MTT) dye [18]. HUVECs were seeded in 24-well plates
coated with 0.2 % gelatine at a density of 2 × 104 cells per
well in 0.5 ml of ECM supplemented with 20 % FBS.
After 24 h, the medium in test wells was replaced by
FBS-free ECM conditioned with e-TRAP, synthetic
TRAP, or EMD at concentrations of 1–100 μg/ml.
Wells, stimulated with FBS-free ECM supplemented with
0.001 % of acetic acid served as vehicle controls. After
24 h incubation, 100 μl of MTT solution (5 mg/ml in
PBS) were added into each well and culture plates were
incubated at 37 °C for 4 h. The medium was removed and
500 μl dimethylsulfoxide (DMSO) were added to each
well, followed by 5 min incubation on a shaker. Finally,
100 μl of each cultured solution were transferred to a
separate 96-well plate and the optical density (OD) was
measured at 570 nm with an ELISA Reader (Molecular
Devices, USA).
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Chemotaxis assay
Cell migration was assessed in a 48-well microchemotaxis
chamber (Neuroprobe, Gaithersburg, MD, USA) as described
previously [19]. The chamber consisted of acrylic top and
bottom plates, each containing 48 matched wells. Twenty-
six microliters of FBS-free medium containing tested sub-
stance (10 μg/ml) were filled in wells of the bottom plate.
Wells filled with medium containing 0.0001 % of acetic acid
served as control. Subsequently, the bottom plate was covered
with a polycarbonate filter with 8-μm pore size (Neuroprobe,
Gaithersburg, MD, USA) and the top plate was applied so that
each well corresponded to that of the bottom plate. 1 × 104
cells resuspended in 50 μl FBS-free medium were added
to each well of the top plate and the whole chamber was
incubated at 37 °C in humidified air with 5 % CO2 for
8 h. After incubation, cells on the upper surface of the
filter were removed over the wiper blade and the filters
were then fixed with methanol and stained using
Hemacolor staining kit (Merck, Darmstadt, Germany).
The cells migrated across the filter were counted under a
light microscope at high-power magnification (×100) to
measure transmigration in each well. Four fields were
counted in each well and the total number was calculated.
Four wells were used for each group; experiments were
repeated in triplicate.
Formation of angiogenic structure in vitro
The formation of angiogenic structures in vitro was performed
using angiogenesis assay kit (Life Technologies, Grand
Island, NY, USA) according to manufacturer’s instruction.
5 × 104 cells were seeded in a 4-well plate precoated with
Geltrex Matrix in 0.5 ml of medium 200 supplemented with
large vessel endothelial supplement (all from Life
Technologies). Cells were cultured in the presence of e-
TRAP, synthetic TRAP, or EMD at a concentration of
10 μg/ml. Cells cultures in the presence of 0.0001 % of acetic
acid were used as a vehicle control. After 15 h, digital images
were obtained using light microscope (Nikon Eclipse TS100)
with mounted digital camera.
Measurements of gene expression levels by quantitative
real-time PCR
Messenger RNA (mRNA) expression levels of E-selectin,
intracellular adhesion molecules (ICAM-1), FMS-like ty-
rosine kinase 1 (FLT-1), kinase insert domain receptor
(KDR), angiopoietin-2 (ang-2), and von Willebrand fac-
tor (vWF) were determined by qPCR similarly to the
method described in our previous studies [20–22].
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
was used as a house-keeping gene. HUVECs were
seeded in 24-well plates similar to MTT experiments
and stimulated in FBS-free ECM with e-TRAP, synthetic
TRAP, or EMD at concentrations of 10 and 50 μg/ml.
Cells stimulated with FBS-free ECM supplemented with
0.001 % of acetic acid served as vehicle control.
Isolation of total cellular mRNA and transcription into
cDNA was performed using the TaqMan Gene
Exp r e s s i on Ce l l s - t o -CT k i t (Amb ion /App l i ed
Biosystems, CA, USA) according to manufacturer’s in-
structions. Real-time PCR was performed on an Applied
Biosystems Step One Plus real-time PCR instrument
(Applied Biosystems, CA, USA) using TaqMan® gene
expression assays with the following ID numbers (all
from Applied Biosystems, CA, USA): E-selectin,
Hs00174057_m1; ICAM-1, Hs00164932_m1; FLT-1,
Hs01052961; KDR-1, Hs00911700_m1; ang-2 ,
Hs01048043_m1; vWF, Hs00169795_m1; GAPDH,
Hs99999905_m1). Duplicate PCR reactions were pre-
pared and the point at which the PCR product was first
detected above a fixed threshold (termed cycle threshold,
Ct), was determined. Changes in the expression of target
genes were calculated using 2−ΔΔCt method, where
ΔΔCt= (Ct
target−CtGAPDH)sample− (Cttarget−CtGAPDH)vehicle
control.
Measurements of cell surface protein expression by flow
cytometry
The expression of adhesion molecules ICAM-1 as well as
VEGF receptors FLT-1 and KDR on the cell surface of
HUVECs was measured by fluorescence flow cytometry
[22]. For the measurements of ICAM-1 expression, one part
of cells was stained with phycoerythrin-conjugated mouse
anti-human ICAM-1 antibody, whereas other part of cells
was stained with corresponding isotype control antibody (all
eBioscience, San Diego, CA, USA). Surface expression of
different proteins was analyzed using a flow cytometer
(FACScan, Becton Dickinson, San Jose, CA, USA). Cell
counting was limited by 5000 events and the mean fluores-
cence intensities values were determined for each sample. The
expression of ICAM-1 and E-selectin for each sample was
quantified using Cell Quest software (Becton Dickinson,
San Jose, CA, USA) based on mean fluorescence intensity
values of cells stained with ICAM-1 and E-selectin antibodies
[23]. Unspecific staining was assessed by measuring cells
stained with the isotype control antibody. For the measure-
ments of FLT-1 and KDR expression cells were stained with
primary rabbit polyclonal andibodies (all Santa Cruz
Biotechnology, Dallas, Texas, USA) and subsequently with
secondary goat anti-rabbit antibody conjugated with FITC
(eBioscience, San Diego, USA). The percentage of FLT-1-
and KDR-positive cells was analyzed by Cell Quest software
(Becton Dickinson, San Jose, CA, USA).
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ELISA analysis
Commercially available ELISA kits were used for measure-
ments of vWF (Novateinbio, Woburn, MA, USA) and ang-2
(RayBiotech, Inc., Norcross GA, USA). Before the measure-
ments of vWF and ang-2, samples of conditioned media were
diluted with corresponding assay diluent by the ratio 1:10.
Statistical analysis
The normal distribution of all data was tested with the
Kolmogorov-Smirnov test. For normally distributed data, the
statistical differences between different groups were analyzed
by one-way analysis of variance (ANOVA) for repeated mea-
sures followed by post hoc LSD-test. For non-normally dis-
tributed data, the statistical differences between groups were
analyzed by Friedman test and pairwise comparison was per-
formed using Wilcoxon test for paired variables. All statistical
analysis was performed using statistical program SPSS 19.0
(SPSS, Chicago, IL, USA). Data are expressed as
mean ± S.E.M. Differences were considered to be statistically
significant at p < 0.05.
Results
Effect of different substances on proliferation/viability of
HUVECs measured in MTT assay is shown on the Fig. 1.
Proliferation/viability of HUVECs was significantly de-
creased by both e-TRAP and synthetic TRAP at concentration
of 100 μg/ml but was not affected by lower concentrations of
these substances (1–10 μg/ml). Treatment of HUVECs with
EMD at a concentration of 100 μg/ml increased proliferation/
v iabi l i ty s igni f icant ly compared to lower EMD
concentrations.
Migration of HUVECs through 8 μm polycarbonate filter
measured in the Boyden chamber was stimulated by all sub-
stances at a concentration of 10 μg/ml (Fig. 2). The number of
cells migrated through the membrane after stimulation with
either e-TRAP or synthetic TRAP was significantly higher
than that after stimulation with EMD (p < 0.05).
Formation of angiogenic structures in vitro was stimulated
by e-TRAP, synthetic TRAP, and EMD at a concentration of
10 μg/ml. As can be seen on original photos of angiogenesis
assay (Fig. 3), all substances induced more branching points
and larger vessel structures. No qualitative differences in the
formation of angiogenic structures between different sub-
stances were observed.
Both e-TRAP and synthetic TRAP at a concentration of
50 μg/ml induced a significant increase in the mRNA expres-
sion level of adhesion molecules ICAM-1 and E-selectin in
HUVECs (Fig. 4). The effect of both TRAP preparations was
not different from that of EMD at similar concentration.
Expression of ICAM-1 on the surface of HUVECs was sig-
nificantly increased by both TRAP preparations at a concen-
tration of 50 μg/ml (Fig. 5). This effect was similar to those of
EMD (50 μg/ml). The expression of E-selectin on the surface
of HUVECs was not detected by flow cytometry (data not
shown).
The mRNA expression levels of VEGF receptors FLT-1
and KDR were significantly upregulated by both e-TRAP
and synthetic TRAP at a concentration of 50 μg/ml
(p < 0.05, Fig. 6a, c). This effect was similar to that of
EMD. The percentage of FLT-1 and KDR-positive cells was
significantly increased by all substances at a concentration of
50 μg/ml (Figs. 6b, d).
The mRNA expression levels of vWF was significantly
increased by both e-TRAP and synthetic TRAP (Fig. 7a) at
a concentration of 50 μg/ml. Similar increase in the vWF
mRNA expression levels in HUVECs was observed upon
stimulation with EMD at similar concentration. The content
Fig. 1 Effect of e-TRAP, synthetic TRAP, and EMD on HUVEC
proliferation/viability. Proliferation/viability of HUVECs was measured
by MTT assay. HUVECs were treated for 24 h with 1–100 μg/ml e-
TRAP, synthetic TRAP, or EMD. Cells treated with 0.001 % of acetic
acid were taken as vehicle control. The values of optical density (OD) of
the different concentrations were normalized to the average OD value of
the control group (=1). Data are presented as mean ± S.E.M. #P < 0.01,
significantly higher than the control. *P < 0.01, significantly lower
compared to the control
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of vWF in the conditioned media was significantly increased
upon stimulation with all substances at a concentration of
50 μg/ml (Fig. 7b). No significant difference in the effects of
different substances was observed.
No significant effect of either e-TRAP or synthetic TRAP
(10–50 μg/ml) on the ang-2 mRNA expression levels in
HUVECs was observed (Fig. 8a). Similarly, the content of
ang-2 in conditioned media was not significantly influenced
by these substances (Fig. 8b). In contrast, EMD at a concen-
tration of 50 μg/ml induced significant increase in the mRNA
expression levels and protein production of ang-2 by
HUVECs.
Discussion
Commercially EMD-based product Emdogain is successfully
used for regeneration of periodontal defects and wound
healing since more than 10 years. Process of neovasculariza-
tion plays an important role in all phases of wound healing:
hemostatic clot formation provides a provisional matrix for
tissue formation; blood vessels supply nutrients and oxygen
and facilitate access of inflammatory cells to the wound
[7, 24]. Several studies report that EMD stimulates angiogen-
esis both in vitro and in vivo; however, the exact EMD com-
ponents responsible for its angiogenic activity are not exactly
known. In the present study, we have investigated the effect of
TRAP, a low molecular weight peptide and one component of
EMD, on endothelial cells in vitro, in order to explore its
potential role in angiogenesis and wound healing.
The proliferation/viability of HUVECs measured by MTT
assay was significantly decreased after treatment e-TRAP and
synthetic TRAP at concentration of 100 μg/ml. In contrast,
EMD itself at similar concentration stimulated the
proliferation/viability of HUVECs. MTT assay is based on
the measurements of formazan formation by cells mitochon-
dria and therefore is often used as a measure of proliferation of
viable cells [25, 26]. Discrepancy in the effects of TRAP and
EMD could be accounted by different apoptotic activity of
TRAP compared to EMD. Indeed, it is known that EMD at
concentrations higher than 100 μg/ml induces apoptosis of
endothelial cells [9], which might be related to the presence
of some cytotoxic substances in EMD. It is possible that
TRAP preparations also possess some cytotoxicity, which
Fig. 3 Effect of e-TRAP, synthetic TRAP, and EMD on the formation of
angiogenic structures by HUVECs in vitro. Formation of angiogenic
structure by HUVECs was detected using angiogenesis kit (Life
Technologies) in the presence of e-TRAP, synthetic TRAP, and EMD at
a concentration of 10 μg/ml. Cells treated with 0.0001% acetic acid were
used as a vehicle control. Photos are made using light microscope at
magnification ×4
Fig. 2 Effect of e-TRAP,
synthetic TRAP, and EMD on the
migration of HUVECs measured
in the microchemotaxis chamber.
The number of cells migrated
through 8μmpolycarbonate upon
stimulation with e-TRAP,
synthetic TRAP, or EMD is
shown. Stimulation with
0.0001 % of acetic acid served as
the control. Data are presented as
mean ± S.E.M. *P < 0.01,
significantly higher compared to
the control. #P < 0.05,
significantly different between
groups
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appears at lower concentrations compared to EMD. The apo-
ptotic activity of TRAP and EMD might also play an impor-
tant role in the processes of periodontal tissue regeneration.
The process of apoptosis is tightly associated with altered
activity of matrix-metalloproteinase (MMP) family proteins
[27]. As shown by a previous study, several MMP proteins,
namely, MMP-2, MMP-9, and MMP-20 play an important
role in the processing and maturation of dental matrix [28].
However, the exact role of MMP proteins in the regenerative
effect of TRAP and EMD remains to be elucidated.
Migration of HUVECs measured in the microchemotaxis
chamber was strongly stimulated by both TRAP preparations.
Moreover, chemotactic ability of TRAP was even higher than
that of EMD. Migration of endothelial progenitor cells to the
wound cite is a pre-requisite for new vessel formation and
therefore is one of the key processes in angiogenesis [29].
This finding is in line with previous observation showing that
synthetic TRAP also stimulates migration of human periodon-
tal ligament cells and HUVECs measured in wound healing
assay [15].
We further observed that both TRAP preparation stimulat-
ed formation of angiogenic structures in vitro by HUVECs.
Formation of tubular structures is considered as one of the
main features of angiogenic differentiation [30]. Thus,
TRAPmight confer the ability of EMD to stimulate angiogen-
esis in vitro observed in some previous studies [9, 10, 31].
This conclusion is also supported by recent study showing
that TRAP promotes formation of tubular structures by human
periodontal ligament cells [15]. HUVECs are often used as a
model of endothelial cells in vitro and are thought to contain a
complete hierarchy of endothelial progenitor cells derived
from the human umbilical cord [32]. Periodontal ligament
cells represent a heterogeneous cell population containing
some mesenchymal progenitor cells [33]. Therefore, TRAP
seems to stimulate angiogenic differentiation of different types
of progenitor cells.
In the present study, we found that both TRAP prepara-
tions, similarly to EMD, upregulated the expression of adhe-
sion molecules ICAM-1 and E-selectin in HUVECs. These
proteins are usually expressed on endothelial cells surface
and mediate the adhesion of inflammatory cells to the endo-
thelium and their subsequent migration to wound sites
[34, 35]. As recently reviewed, EMD might affect inflamma-
tory response in different cell types, which contribute to its
regenerative ability [36]. Our data suggest that TRAP might
have a positive effect in the inflammatory phase of wound
Fig. 5 Effect of e-TRAP, synthetic TRAP, and EMD on surface
expression of ICAM-1 HUVECs were stimulated with e-TRAP,
synthetic TRAP, or EMD at a concentration of 50 μg/ml for 24 h and
stained with phycoerythrin-conjugated anti-ICAM-1 antibody. Mean
fluorescence intensity (m.f.i.) values of cells stained with ICAM-1
antibodies were corrected for unspecific staining by subtracting the
fluorescence of cells stained with the isotype control antibody. Cells
treated with 0.0005 % acetic acid served as vehicle control. Data are
presented as mean ± S.E.M. *P < 0.01, significantly higher compared
to vehicle control
Fig. 4 Effect of e-TRAP, synthetic TRAP, and EMD on mRNA
expression of adhesion molecules ICAM-1 and E-selectin. Relative
expression level of ICAM-1 (a) and E-selectin ICAM-1 (b) genes upon
incubation with e-TRAP, synthetic TRAP, or EMD at concentrations 10
or 50 μg/ml for 24 h. GAPDH was used as endogenous control gene.
ECM supplemented with 0.0005 % acetic acid served as vehicle control
(=1). Data are presented as mean ± S.E.M. *P < 0.01, significantly higher
compared to vehicle control
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healing and might be also involved in other inflammation-
related effects of EMD. Furthermore, both TRAP preparations
induced an increase in the expression of vWF in HUVEC on
both gene and protein levels. Previous report shows that syn-
thetic TRAP might also induce vWF expression on periodon-
tal ligament cells [15]. vWF is involved in the platelet
adhesion, and platelet, in turn, might release several factors
supporting angiogenesis and wound healing [37, 38].
Both e-TRAP and synthetic TRAP enhanced the expres-
sion of VEGF receptors KDR and FLT-1 in HUVECs. VEGF
is well-known growth factors playing a central role in angio-
genesis and vessel formation [39]. VEGF receptors FLT-1 and
Fig. 7 Effect of e-TRAP, synthetic TRAP, and EMDon the expression of
vWF in HUVECs. a Relative gene expression level of von Willebrand
factor upon stimulation with e-TRAP, synthetic TRAP, or EMD at
concentrations 10–50 μg/ml for 24 h. GAPDH was used as endogenous
control gene. ECM supplemented with 0.0005 % acetic acid served as
vehicle control (=1). c, b The levels of vWF proteins in conditioned
media measured by commercially available ELISA. Data are presented
as mean ± S.E.M. *P < 0.01, significantly higher compared to vehicle
control
Fig. 6 Effect of e-TRAP, synthetic TRAP, or EMD on the expression of
VEGF receptors FLT-1 and KDR. a, c Relative gene expression levels of
FLT-1 (a) and KDR (c) in HUVECs upon incubation with e-TRAP,
synthetic TRAP, or EMD at concentrations 10–50 μg/ml for 24 h.
GAPDH was used as endogenous control gene. Cells treated with
0.0005 % acetic acid served as vehicle control (=1). b, d Percentage of
FLT-1 and KDR-positive cells measured by flow cytometry after
stimulation with the same substances. Data are presented as
mean ± S.E.M. *P < 0.01, significantly higher compared to vehicle
control
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KDR are localized on the endothelial cell surface and play an
important role in endothelial cells differentiation and organi-
zation of blood vessels [40]. Interestingly, previous studies
show that EMD upregulate the production of VEGF by dif-
ferent cells of periodontium, such as human gingival and peri-
odontal ligament fibroblasts [10, 41, 42]. Thus, it seems EMD
and/or TRAP promote the paracrine interaction between dif-
ferent cell types during the process of wound healing through
increased expression of both ligand and receptors. This hy-
pothesis is supported by a recent clinical study, in which the
application of Emdogain onto the root surface and into the
periodontal pocket resulted in the increase of VEGF expres-
sion and microvessel density in gingival tissues [5]. It is
known that endothelial cell migration is stimulated by activa-
tion KDR by VEGF [43]. This suggests that TRAPmight also
improve interaction between different cell types and by pro-
moting both VEGF release by resident fibroblasts and VEGF
response by endothelial cells.
Interestingly, the effect of both TRAP preparations on the
expression of different proteins was similar to that of EMD at
similar concentration. This fact is rather surprising and is dif-
ficult to explain. However, in a study on mice, the highest
in vivo angiogenic activity of 6 kDa protein (presumably
TRAP) was observed in amount of 50 ng, which was higher
compared to other proteins [6]. A recent study on periodontal
ligament cells shows that cell activation cells by TRAP is a
complicated process, which involves both interaction with cell
surfaces and internalization through endocytosis [44].
Different TRAP activation mechanisms might also result in
different concentration dependency. However, the mecha-
nisms of TRAP interaction with endothelial cells are currently
unknown and remain to be studied in the future.
No significant effect of any TRAP preparation on the
expression of ang-2 was observed. In contrast, EMD in-
duced a significant increase in the expression of ang-2 on
both gene and protein levels. ang-2 is involved in vessel
maturation and facilitates endothelial cell responsiveness
to angiogenic and inflammatory stimuli [45, 46]. This ob-
servation means that besides TRAP some other EMD pro-
teins and/or peptides are involved in the angiogenic activ-
ity of EMD. This statement is supported by a recent study
on mice, in which the effect of the so-called EMD-derived
protein pools with different molecular weights on blood
vessel formation was investigated in vivo [6]. The authors
find the highest angiogenic activity for EMD protein pools
containing proteins with a molecular weight of 25, 7, and
5 kDa. In our study, we used TRAP isolated from EMD as
well as synthetic TRAP, which did not contain other pro-
teins. The contribution of other EMD components, such as
leucine-rich amelogenin peptide (LRAP), shealthin,
enamelin, ameloblastin, and tuftelin into angiogenesis re-
main to be clarified. However, it requires isolation of rela-
tively pure peptides.
Several previous studies investigated the effect of EMD
protein fraction with molecular weight about 5 kDa, which
is presumably composed by TRAP, on angiogenesis, but
their results are partially controversial: some studies sug-
gest an angiogenic activity of 5 kDa EMD protein [6, 15,
31], whereas other study report no effect of 5 kDa EMD
protein on the blood vessel formation in the chorioallantoic
membrane of the developing chicken eggs [47]. In con-
trast, synthetic TRAP is shown to stimulate angiogenesis
in chicken egg model [15]. This suggests that TRAP prep-
aration method might be an important factor influencing its
biological activity.
Summarizing, our data as well as the results of previous
studies provided evidences that TRAP possess angiogenic ac-
tivity. TRAP might be used in the designing of new EMD-
based product emphasized on specific aspects of tissue
regeneration.
Fig. 8 Effect of e-TRAP, synthetic TRAP, and EMDon the expression of
ang-2 in HUVECs. a Relative gene expression level of angiopoietin-2
upon stimulation with e-TRAP, synthetic TRAP, or EMD at
concentrations 10–50 μg/ml for 24 h. GAPDH was used as endogenous
control gene. ECM supplemented with 0.0005 % acetic acid served as
vehicle control (=1). c, b The levels of ang-2 proteins in conditioned
media measured by commercially available ELISA. Data are presented
as mean ± S.E.M. *P < 0.01, significantly higher compared to vehicle
control
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